Publications in collaboration with researchers from Hospital Universitario de la Princesa (2)

2019

  1. Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study

    Breast Journal, Vol. 25, Núm. 2, pp. 219-225

2014

  1. Aldehyde dehydrogenases in early stage lung cancer: nuclear expression

    Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 931-934